138 related articles for article (PubMed ID: 15650785)
21. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
[TBL] [Abstract][Full Text] [Related]
22. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus.
Claeys H; Volckaerts A; Mertens W; Liang Z; Fiten P; Opdenakker G
J Med Virol; 1995 Mar; 45(3):273-81. PubMed ID: 7539833
[TBL] [Abstract][Full Text] [Related]
23. Immunodominant regions within the hepatitis C virus core and putative matrix proteins.
Sällberg M; Rudén U; Wahren B; Magnius LO
J Clin Microbiol; 1992 Aug; 30(8):1989-94. PubMed ID: 1380007
[TBL] [Abstract][Full Text] [Related]
24. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
25. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
[TBL] [Abstract][Full Text] [Related]
26. Use of Synthetic Peptides and Multiple Antigen Blot Assay in the Immunodiagnosis of Hepatitis C Virus Infection.
Gauna A; Losada S; Lorenzo M; Toledo M; Bermúdez H; D'Angelo P; Sánchez D; Noya O
Viral Immunol; 2018 Oct; 31(8):568-574. PubMed ID: 30256730
[TBL] [Abstract][Full Text] [Related]
27. Immune Reactivity of Synthetic Peptides Originated from Hypervariable Region 1 of Hepatitis C Synthetic Consensuses with Egyptian Sera Infected with Hepatitis C Virus Type 4.
Abdel-Fattah M; Charmy R; Tawfik AR
Intervirology; 2015; 58(4):232-41. PubMed ID: 26330263
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction.
Zhang ZX; Yun ZB; Chen M; Sönnerborg A; Sällberg M
J Med Virol; 1995 Jan; 45(1):50-5. PubMed ID: 7536231
[TBL] [Abstract][Full Text] [Related]
29. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.
Ray R; Khanna A; Lagging LM; Meyer K; Choo QL; Ralston R; Houghton M; Becherer PR
J Virol; 1994 Jul; 68(7):4420-6. PubMed ID: 8207814
[TBL] [Abstract][Full Text] [Related]
30. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
31. Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.
Kelly C; Swadling L; Brown A; Capone S; Folgori A; Salio M; Klenerman P; Barnes E
Eur J Immunol; 2015 Jan; 45(1):309-16. PubMed ID: 25263407
[TBL] [Abstract][Full Text] [Related]
32. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis.
Rosa C; Osborne S; Garetto F; Griva S; Rivella A; Calabresi G; Guaschino R; Bonelli F
J Virol Methods; 1995 Oct; 55(2):219-32. PubMed ID: 8537460
[TBL] [Abstract][Full Text] [Related]
33. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
[TBL] [Abstract][Full Text] [Related]
34. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
Jackson P; Petrik J; Alexander GJ; Pearson G; Allain JP
J Med Virol; 1997 Jan; 51(1):67-79. PubMed ID: 8986952
[TBL] [Abstract][Full Text] [Related]
35. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.
Bhattacherjee V; Prescott LE; Pike I; Rodgers B; Bell H; El-Zayadi AR; Kew MC; Conradie J; Lin CK; Marsden H
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1737-48. PubMed ID: 9049379
[TBL] [Abstract][Full Text] [Related]
36. Antigenic epitopes of the hepatitis A virus polyprotein.
Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
[TBL] [Abstract][Full Text] [Related]
37. Antigenic heterogeneity of the NS3 proteins in hepatitis C virus genotypes 1 and 6.
Qiao W; Xie P; Cai B; Li L
Intervirology; 2011 Feb; 54(2):53-60. PubMed ID: 20829600
[TBL] [Abstract][Full Text] [Related]
38. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
39. Evidence of subtype-specific antibodies to antigenic epitopes in the NS5 region of hepatitis C virus in the circulation of patients with chronic hepatitis C.
Quiroga JA; Martin J; Pernas M; Pardo M; Herrero M; Castillo I; Bartolome J; Carreño V
Clin Diagn Lab Immunol; 1994 Sep; 1(5):545-51. PubMed ID: 8556499
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
Kim Y; Vaughan K; Greenbaum J; Peters B; Law M; Sette A
PLoS One; 2012; 7(5):e38028. PubMed ID: 22675428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
